×
0 0 0 0 0 0.0218181818181818 0.0218181818181818 0.0181818181818183
Stockreport

Celldex Therapeutics: Make-or-Break-It Data Expected Soon [The Motley Fool]

CELLDEX THERAPEUTICS (CLDX)  More Company Research Source: The Motley Fool
Last celldex therapeutics earnings: 8/8 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.celldex.com
PDF Upcoming data may make this an intriguing clinical-stage biotech stock to buy. On Wednesday, Celldex Therapeutics ( NASDAQ:CLDX )  reported fourth-quarter financials. However, that wasn't what caused its shares to jump on Thursday. Instead, it was management's clinical-trial progress that sparked investor's optimism. Specifically, the company expects to report pivotal phase 2b trial data for glembatumumab vedotin (glemba) soon, and if that data is good, it could move this stock out of biotech's bargain bin. Back on track? Celldex Therapeutics investors saw the value of their shares more than cut in half after the company's Rintega flopped in a late-stage brain cancer trial in 2016. The disappointment sent shares reeling and forced management to execute a major restructuring, something that investors hope won't happen again when management reports glemba results in breast cancer patients next quarter. IMAGE SOURCE: GETTY IMAGES. Those results will show wh [Read more]

IMPACT SNAPSHOT EVENT TIME: CLDX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
CLDX alerts

from News Quantified
Opt-in for
CLDX alerts

from News Quantified